Skip to main content
OpenTrials

Clinical trial condition

Hypercholesterolaemia

Explore clinical trials studying Hypercholesterolaemia. Study availability and eligibility vary by location and protocol.

38 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Hypercholesterolaemia trial results

Completed

Usability Study of the Commercial Auto-injector Device and the New Auto-injector Device (SYDNEY) in Patients With High or Very High CV Risk With Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy

NCT03415178

Conditions
Dyslipidemias, Hypercholesterolaemia, Hypercholesterolemia, +4 more
Locations
  • Investigational Site Number 8400024 Los Angeles, California, United States
  • Investigational Site Number 8400007 Jacksonville, Florida, United States
  • Investigational Site Number 8400017 Jacksonville, Florida, United States
  • Investigational Site Number 8400013 Ponte Vedra, Florida, United States
View all 13 locations
View Trial Details
Completed

An 8-Week Dose-Finding Study to Evaluate the Efficacy and Safety of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia

NCT02890992

Conditions
Dyslipidemias, Hypercholesterolaemia, Hypercholesterolemia, +4 more
Locations
  • Investigational Site Number 8400002 St Louis, Missouri, United States
  • Investigational Site Number 8400005 Charlotte, North Carolina, United States
  • Investigational Site Number 8400001 Cincinnati, Ohio, United States
  • Investigational Site Number 1240001 Québec, Canada
View all 16 locations
View Trial Details
Completed

Efficacy and Safety of Alirocumab Versus Placebo on Top of Maximally Tolerated Lipid Lowering Therapy in Patients With Hypercholesterolemia Who Have Type 1 or Type 2 Diabetes and Are Treated With Insulin (ODYSSEY DM - Insulin)

NCT02585778

Conditions
Dyslipidemias, Hypercholesterolaemia, Hypercholesterolemia, +4 more
Locations
  • Investigational Site Number 840020 Encino, California, United States
  • Investigational Site Number 840002 Fresno, California, United States
  • Investigational Site Number 840029 Oakland, California, United States
  • Investigational Site Number 840027 Loveland, Colorado, United States
View all 110 locations
View Trial Details
Completed

Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia (ODYSSEY HIGH FH)

NCT01617655

Conditions
Dyslipidemias, Hypercholesterolaemia, Hypercholesterolemia, +4 more
Locations
  • Investigational Site Number 840742 Bell Gardens, California, United States
  • Investigational Site Number 840703 Newport Beach, California, United States
  • Investigational Site Number 840712 Newport Beach, California, United States
  • Investigational Site Number 840743 Northridge, California, United States
View all 35 locations
View Trial Details
Completed

Evaluation of Patients Treated With HMG-CoA Reductase Inhibitors to Reach Cholesterol Target Values

NCT01483950

Conditions
Dyslipidemias, Hypercholesterolaemia, Hypercholesterolemia, +4 more
Locations
  • Research Site Banja Luka, Bosnia and Herzegovina
  • Research Site Bijeljina, Bosnia and Herzegovina
  • Research Site Doboj, Bosnia and Herzegovina
  • Reserach Site Gradiska, Bosnia and Herzegovina
View all 14 locations
View Trial Details

Related conditions